These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16289419)

  • 1. Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice.
    Obara K; Ishihara M; Ozeki Y; Ishizuka T; Hayashi T; Nakamura S; Saito Y; Yura H; Matsui T; Hattori H; Takase B; Ishihara M; Kikuchi M; Maehara T
    J Control Release; 2005 Dec; 110(1):79-89. PubMed ID: 16289419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
    Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
    J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled releases of FGF-2 and paclitaxel from chitosan hydrogels and their subsequent effects on wound repair, angiogenesis, and tumor growth.
    Ishihara M; Fujita M; Obara K; Hattori H; Nakamura S; Nambu M; Kiyosawa T; Kanatani Y; Takase B; Kikuchi M; Maehara T
    Curr Drug Deliv; 2006 Oct; 3(4):351-8. PubMed ID: 17076636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel.
    Shim WS; Kim JH; Kim K; Kim YS; Park RW; Kim IS; Kwon IC; Lee DS
    Int J Pharm; 2007 Feb; 331(1):11-8. PubMed ID: 17049773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
    Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC
    J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model.
    Fujita M; Ishihara M; Shimizu M; Obara K; Nakamura S; Kanatani Y; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T
    Wound Repair Regen; 2007; 15(1):58-65. PubMed ID: 17244320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of chitosan with fibroblast growth factor-2 and its protection from inactivation.
    Masuoka K; Ishihara M; Asazuma T; Hattori H; Matsui T; Takase B; Kanatani Y; Fujita M; Saito Y; Yura H; Fujikawa K; Nemoto K
    Biomaterials; 2005 Jun; 26(16):3277-84. PubMed ID: 15603823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel.
    Ho EA; Vassileva V; Allen C; Piquette-Miller M
    J Control Release; 2005 May; 104(1):181-91. PubMed ID: 15866344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan hydrogel as a drug delivery carrier to control angiogenesis.
    Ishihara M; Obara K; Nakamura S; Fujita M; Masuoka K; Kanatani Y; Takase B; Hattori H; Morimoto Y; Ishihara M; Maehara T; Kikuchi M
    J Artif Organs; 2006; 9(1):8-16. PubMed ID: 16614797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution.
    Saravanakumar G; Min KH; Min DS; Kim AY; Lee CM; Cho YW; Lee SC; Kim K; Jeong SY; Park K; Park JH; Kwon IC
    J Control Release; 2009 Dec; 140(3):210-7. PubMed ID: 19560497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models.
    Springate CM; Jackson JK; Gleave ME; Burt HM
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):239-47. PubMed ID: 15864591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceleration of wound healing in healing-impaired db/db mice with a photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2.
    Obara K; Ishihara M; Fujita M; Kanatani Y; Hattori H; Matsui T; Takase B; Ozeki Y; Nakamura S; Ishizuka T; Tominaga S; Hiroi S; Kawai T; Maehara T
    Wound Repair Regen; 2005; 13(4):390-7. PubMed ID: 16008728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization.
    Nakamura S; Ishihara M; Obara K; Masuoka K; Ishizuka T; Kanatani Y; Takase B; Matsui T; Hattori H; Sato T; Kariya Y; Maehara T
    J Biomed Mater Res A; 2006 Aug; 78(2):364-71. PubMed ID: 16673389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization.
    Nakamura S; Nambu M; Ishizuka T; Hattori H; Kanatani Y; Takase B; Kishimoto S; Amano Y; Aoki H; Kiyosawa T; Ishihara M; Maehara T
    J Biomed Mater Res A; 2008 Jun; 85(3):619-27. PubMed ID: 17806115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable chitosan hydrogels for localised cancer therapy.
    Ta HT; Dass CR; Dunstan DE
    J Control Release; 2008 Mar; 126(3):205-16. PubMed ID: 18258328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
    Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C
    Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation of functional chitosan thermosensitive hydrogel for slow release both rhBMP-2 and chlorhexidine].
    Ma ZW; Wang R; Wu ZF; Chen D; Zhang BL; He W; Wang XJ; Liu Q; Xu J; Zhu H
    Sheng Wu Gong Cheng Xue Bao; 2007 Nov; 23(6):1049-54. PubMed ID: 18257235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro anti-cancer activity of thermo-sensitive and photo-crosslinkable doxorubicin hydrogels composed of chitosan-doxorubicin conjugates.
    Cho YI; Park S; Jeong SY; Yoo HS
    Eur J Pharm Biopharm; 2009 Sep; 73(1):59-65. PubMed ID: 19409990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chitosan hydrogel containing DMEM/F12 medium on full-thickness skin defects after deep dermal burn.
    Kiyozumi T; Kanatani Y; Ishihara M; Saitoh D; Shimizu J; Yura H; Suzuki S; Okada Y; Kikuchi M
    Burns; 2007 Aug; 33(5):642-8. PubMed ID: 17475411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.